🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study.

PMID: 41731727 · DOI: 10.1177/13872877261419066 · Journal of Alzheimer's disease : JAD, 2026 · Maliha Hakim, Redoy Ranjan, Gie Ken-Dror, Md Abdullah Yusuf, Mohammad Nur Uddin, Mim Tanzila Mamun, Alif Al Mamun, Ghula
📄 Abstract

BackgroundAlthough the molecular basis of Alzheimer's disease (AD) is often studied in Caucasians, its genetic basis in Bangladesh remains elusive.ObjectiveWe explored the association between single-nucleotide variants (SNVs) of Apolipoprotein E (

Confidence: 0.02 · 1 полей извлечено
Идентификация (6 полей)
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
0.00
In vivo
0.00
In silico
0.00
Genetic association
Next-generation sequencing study identifies first genes associated with Alzheimer's disease in Bangladeshi population; multi-ancestry exome-wide study identifies variants associated with Alzheimer's disease protection; brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease; genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias
0.90
Ex vivo
0.00
Animal model
0.00
Diet/model
0.00
Клиника (11 полей)
Drug
0.00
Indication
0.00
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00